Drug Profile
Monoclonal antibody MINT5
Alternative Names: Anti-EGFR monoclonal antibody MINT5Latest Information Update: 19 Sep 2001
Price :
$50
*
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Epidermal growth factor inhibitors; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Lung cancer
Most Recent Events
- 19 Sep 2001 No-Development-Reported for Lung cancer in Italy (IV)
- 19 Sep 2001 No-Development-Reported for Lung cancer in Spain (IV)
- 22 Jun 1997 Phase-II clinical trials for Lung cancer in Italy (IV)